ArticleJournal of translational medicine2023

Leveraging circulating microbiome signatures to predict tumor immune microenvironment and prognosis of patients with non-small cell lung cancer.

Xiaohan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.